![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 11 December 2024
Sec. Neuropharmacology
Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1508703
This article is a correction to:
Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage
by Chen Q, Cai Y, Zhu X, Wang J, Gao F, Yang M, Mao L, Zhang Z and Sun B (2022). Front. Pharmacol. 13:848529. doi: 10.3389/fphar.2022.848529
In the published article, there was an error in Supplementary Image 1. The inclusion of multiple brain images in the figure led to a typesetting oversight, resulting in the duplication of two brain images within the PBS and Eda Dexborneol groups. The correct Supplementary Image 1 is now published with the published article.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: oxidative stress, subarachnoid hemorrhage, edaravone dexborneol, 4-HNE, edaravone
Citation: Chen Q, Cai Y, Zhu X, Wang J, Gao F, Yang M, Mao L, Zhang Z and Sun B (2024) Corrigendum: Edaravone dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage. Front. Pharmacol. 15:1508703. doi: 10.3389/fphar.2024.1508703
Received: 09 October 2024; Accepted: 20 November 2024;
Published: 11 December 2024.
Edited and reviewed by:
Rui Liu, Chinese Academy of Medical Sciences and Peking Union Medical College, ChinaCopyright © 2024 Chen, Cai, Zhu, Wang, Gao, Yang, Mao, Zhang and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Leilei Mao, bGVpbGVpLTAzMThAMTYzLmNvbQ==; Zongyong Zhang, enl6aGFuZ0BzZGZtdS5lZHUuY24=; Baoliang Sun, YmxzdW44OEAxNjMuY29t
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.